Komori
Precision System Science (7707) · TargetSoftened

Performance Targets for the Fiscal Year Ending June 2019

First written in FY2016. 7 of 12 entries say "Softened", first in FY2018. Latest entry: FY2026.

12entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseSoftenedFY2018 – FY2019SoftenedFY2022 – FY20262016: 12017: 120172018: 120182019: 120192020: 120202021: 120212022: 120222023: 120232024: 120242025: 120252026: 22026
Same theme, other companies
Setting and Achieving Earnings Targets Under the Medium-Term Management PlanA theme 787 companies write about · 75 as a headwind · 1058 as a tailwind

The whole theme swung hardest in 2021: 17 of 77 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 133 companies compared. The sentences above are computed from all 133.Comparing 200 of the theme's 1178 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026SoftenedAnnual report

    「Meanwhile, in the Summary of Financial Results for the Fiscal Year Ended June 2026 [Japanese GAAP] (Consolidated) announced on 14 August 2026, we set our forecast for consolidated operating income for the fiscal year ending June 2027 at ¥350 million, taking into account changes in the business environment and other factors. While working to achieve this earnings forecast, our group will work to improve its earnings capacity in order to close the gap with the previous target.」

    Against the target of approximately ¥400 million in consolidated operating income at the end of the fiscal year ending June 2027, the earnings forecast was set at ¥350 million. Closing the gap with the previous target was explicitly identified as an issue.
  2. 2026-08-14SoftenedEarnings

    「In the explanatory materials on the business plan and growth potential announced in September 2025, the Company set numerical targets for the fiscal year ending June 2027 of sales of ¥5,564 million and operating income of ¥438 million, and identified them as target management indicators. In light of consolidated results for the fiscal year ending June 2026 and the current operating environment, the targets have been revised to sales of ¥5,650 million and operating income of ¥350 million.」

    2027年6月期の売上高目標は5,564百万円から5,650百万円へ引き上げられた一方、営業利益目標は438百万円から350百万円へ引き下げられた。
  3. FY2025ReframedAnnual report

    「Over the medium to long term, we aim to increase sales by approximately ¥250 million to ¥600 million each fiscal year over the 3-year period from the fiscal year ending June 2025 through the fiscal year ending June 2027, and to achieve consolidated operating income of approximately ¥400 million as of the end of the fiscal year ending June 2027.」

    The target range for annual sales growth was changed from approximately ¥450 million–¥500 million to approximately ¥250 million–¥600 million, while the target of consolidated operating income of approximately ¥400 million at the end of the fiscal year ending June 2027 was maintained.
  4. FY2024SoftenedAnnual report

    「As stated in the Explanatory Materials on the Business Plan and Growth Potential announced on 30 September 2024, over the medium to long term, we aim to increase sales by approximately ¥450 million to ¥500 million each fiscal year over the 3-year period from the fiscal year ending June 2025 through the fiscal year ending June 2027, and to achieve consolidated operating income of approximately ¥400 million as of the end of the fiscal year ending June 2027.」

    The target was changed from the previous goal of ¥10 billion in consolidated net sales and ¥1 billion in consolidated operating income for the fiscal year ending June 2027 to a target of increasing sales by ¥450 million to ¥500 million each fiscal year and achieving operating income of approximately ¥400 million at the end of the fiscal year ending June 2027.
  5. FY2023SoftenedAnnual report

    「We aim to achieve the numerical targets of ¥10 billion in consolidated net sales and ¥1 billion in consolidated operating income during the period from the fiscal year ending June 2025 through the fiscal year ending June 2027.」

    The numerical targets of ¥10 billion in net sales and ¥1 billion in operating income were maintained, but the target timeframe was extended from the previous target of the fiscal year ending June 2025 to a target covering the period from the fiscal year ending June 2025 through the fiscal year ending June 2027.
  6. FY2022SoftenedAnnual report

    「As set out in the business outlook announced on 12 August 2022, we aim to achieve consolidated net sales of ¥10 billion and consolidated operating income of ¥1 billion, with the fiscal year ending June 2025 as the final year.」

    The targets of ¥10 billion in consolidated net sales and ¥1 billion in consolidated operating income were maintained, but the final year was extended from the fiscal year ending June 2023 to the fiscal year ending June 2025.
  7. FY2021RestatedAnnual report

    「Under the medium-term business plan announced on 28 August 2020, we aim to achieve consolidated net sales of ¥10,000 million and consolidated operating income of ¥1,000 million in the fiscal year ending June 2023, the final year of the plan.」

    The medium-term targets of consolidated net sales of ¥10,000 million and consolidated operating income of ¥1,000 million for the fiscal year ending June 2023 remain in place.
  8. FY2020RaisedAnnual report

    「Under the medium-term business plan announced on 28 August 2020, we aim to achieve consolidated net sales of ¥10,000 million and consolidated operating income of ¥1,000 million in the fiscal year ending June 2023, the final year of the plan.」

    The final year was revised from the fiscal year ending June 2021 to the fiscal year ending June 2023, and the targets were raised to net sales of ¥10,000 million and operating income of ¥1,000 million.
  9. FY2019SoftenedAnnual report

    「Under the medium-term business plan announced on 30 August 2019, we aim to achieve consolidated net sales of ¥5,400 million and consolidated operating income of ¥200 million in the fiscal year ending June 2021, the final year of the plan.」

    The final year remained the fiscal year ending June 2021, but the consolidated net sales target was reduced from ¥5,600 million to ¥5,400 million. The consolidated operating income target remained ¥200 million.
  10. FY2018SoftenedAnnual report

    「Under the medium-term business plan announced on 27 August 2018, we aim to achieve net sales of ¥5,600 million and operating income of ¥200 million in the fiscal year ending June 2021, the final year of the plan.」

    The final year was extended from the fiscal year ending June 2020 to the fiscal year ending June 2021. The net sales target was reduced from ¥6,500 million to ¥5,600 million, and the operating income target from ¥550 million to ¥200 million.
  11. FY2017RaisedAnnual report

    「Under the medium-term business plan announced on 14 August 2017, we aim to achieve net sales of ¥6,500 million, operating income of ¥550 million, ordinary income of ¥530 million and net income attributable to owners of the parent of ¥520 million in the fiscal year ending June 2020, the final year of the plan.」

    The targets were updated from the fiscal year ending June 2019 to a new 3-year plan ending June 2020. The targets were raised to net sales of ¥6,500 million, operating income of ¥550 million, ordinary income of ¥530 million and net income attributable to owners of the parent of ¥520 million.
  12. FY2016First statedAnnual report

    「Under the medium-term business plan announced on 12 August 2016, we aim to achieve net sales of ¥5,600 million, operating income of ¥220 million, ordinary income of ¥200 million and net income of ¥190 million in the fiscal year ending June 2019, the final year of the plan.」

    Specific targets for net sales and 3 profit measures through the fiscal year ending June 2019 were recorded for the first time.
Moved together

"Dependence on Sales to Roche Group and QIAGEN Group" moved the same way as this thread, in the same document, in 7 of its 12 moves.

763333★123456
  1. ★This thread
  2. 1Dependence on Sales to Roche Group and QIAGEN Group7×
  3. 2Dependence of sales on the automated DNA extraction system6×
  4. 3Foreign exchange fluctuation risk arising from the scale of overseas sales3×
  5. 4Recurring Losses, Negative Operating Cash Flow and an Early Return to Profitability3×
  6. 5Development of Lower-Cost, More Compact geneLEAD VIII and Multiple Diagnostic Reagents3×
  7. 6Concentration of trade receivables among certain major customers3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Precision System Science yet. It last moved in the Earnings of 2026-08-14: "Softened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Performance Targets for the Fiscal Year Ending June 2019 | Precision System Science Co.,Ltd. (7707) | Komori